$B:G=*99?7F|;~!'(B2020-09-26 15:59:01
$B$3$NJ,N`$G$h$/;H$o$l(B $B$F$$$k%-!<%o!<%I(B | $B%-!<%o!<%I(B | $B | |
---|---|---|---|
crystallization | 4$B7o(B | ||
Amino Acid | 2$B7o(B | ||
Nucleation | 2$B7o(B | ||
supersaturation | 2$B7o(B | ||
Anti-solvent crystallization | 2$B7o(B | ||
Polymorphism | 2$B7o(B | ||
zeolites | 1$B7o(B |
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $BH/I=7A<0(B | |
---|---|---|---|
159 | $B%0%j%7%s$NIOMOG^>=@O$K$*$1$k?eE:2C$rMxMQ$7$?7k>=B?7A$N@)8f(B | Glycine Polymorph Anti-solvent crystallization | P |
210 | L-$B%0%k%?%_%s;@$NB?7A@)8f(B | Amino acid Polymorphism Ultrasonication | P |
211 | $B%7%e%&;@$rMQ$$$?%i%s%?%s7k>=2s<}J}K!$N8!F$(B | Lanthanum Reaction crystallizaton Recovery | P |
213 | L$B%*%k%K%A%s(BL$B%"%9%Q%i%.%s;@1v$NIOMOG^>=@O$K$*$1$k>=JJ@)8f(B | Amino acud Antisolvent crystallization Crystal growth | P |
215 | ZMH$B$NIUCe$K29EYJQ2=$,5Z$\$91F6A(B | Encrusration Reaction crystallization Zirconium Molybdate Hydrate | P |
224 | $B>W7b3K2=$K$*$h$\$9A`:n0x;R$N1F6A(B | Nucleation Supercooled Melt Solid Collision | O |
243 | $BD62;GH>H | Amino Acid Polymorphism Ultrasound | O |
291 | $B%P%K%j%s$NHsMOG^E:2C>=@O$G$N7k>=N3;R72IJ | Anti-solvent crystallization Supersaturation Crystal shape | P |
497 | ZSM-5$B%<%*%i%$%H$N?eG.9g@.$K$*$1$kD62;GH$N1F6A(B | zeolites crystallization ultrasonic | O |
544 | $BD@EBK!$K$h$k;@2=0!1tJ4Kv$N9g@.$H$=$NMO2r5sF0(B | Powder Synthesis Dissolution | P |
622 | $B?75,%+%9%1!<%I7?O"B3%U%m!<>=@O$rMQ$$$?7k>=N3;R72$NIJ | Crystallization Continuous flow Cascade | P |
623 | Anti-solvent$B>=@OK!$K$h$k6&7k>=N3;R72$N(BHomogeneity$BI>2A(B | Crystallization Cocrystal Homogeneity | O |
626 | $B6&>=7O$rMxMQ$7$?MO2rB.EY2~A1$N$?$a$N8GAjJ,;6M;1U>=@OK!(B | Melt crystallization Eutectic Dissolution rate | O |
657 | CO2$B$rMQ$$$?D6NW3&MOBN5^B.KDD%(B(RESS)$BK!$K$h$k%0%j%;%*%U%k%S%s$N%"%b%k%U%!%9%J%NN3;RAO@=(B | Supercritical carbon dioxide Griseofulvin Amorphous nanoparticles | P |
703 | $BB?9&@-G[0L9bJ,;R(BHKUST-1 $B$N7k>=@.D92aDx$NB.EYO@E*2r@O(B | Metal-organic framework Nucleation | O |
718 | $B%"%_%m%$%I7A@.AK328=>]$K4p$E$/%?%s%Q%/2A(B | supersaturation amyloid hydrogen bonding | O |
722 | polygalacturonic acid$B$NG.?eJ,2r$K$h$jF@$i$l$?E|N`$rHoKl$7$?(Bibuprofen$B7k>=$N@8@.(B | Hydrothermal Ibuprofen Coating with sugar | P |
726 | $B;i | crystallization lysozyme lateral diffusion | O |
735 | $B5e>u6E=87k>=$N=cEY$r8~>e$5$;$k>=@O$H%j%9%i%j! | Agglomerated crystal Purity Reslurry | P |
809 | MD$B%7%_%e%l!<%7%g%s$rMQ$$$?3$?e1UE)$NJILLIUCe5sF0$HG($l@-$N1vJ,G;EY0MB8@-(B | seawater droplets Contact angle MD method | P |